Literature DB >> 7913952

Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor.

W R Godfrey1, F F Fagnoni, M A Harara, D Buck, E G Engleman.   

Abstract

The human OX-40 cell surface antigen is a CD4+ T cell activation marker that acts as a costimulatory receptor and is a member of the nerve growth factor receptor/tumor necrosis factor (TNF) receptor family. Using a soluble form of the receptor, the extracellular region fused with human immunoglobulin Fc, we expression cloned the human OX-40 ligand cDNA from a library derived from an activated B lymphoblastoid cell line MSAB. The encoded protein is identified as gp34, a type II transmembrane antigen previously known to be expressed only by human T cell lymphotropic virus 1-infected cells. We describe gp34 as a new member of the TNF family, and find that the recombinant ligand expressed in COS cells costimulates phorbol myristate acetate, phytohemagglutinin, and anti-CD3-induced CD4+ T cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913952      PMCID: PMC2191595          DOI: 10.1084/jem.180.2.757

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Emerging families of cytokines and receptors.

Authors:  J F Bazan
Journal:  Curr Biol       Date:  1993-09-01       Impact factor: 10.834

2.  Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.

Authors:  A Aruffo; B Seed
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Inducible T cell antigen 4-1BB. Analysis of expression and function.

Authors:  K E Pollok; Y J Kim; Z Zhou; J Hurtado; K K Kim; R T Pickard; B S Kwon
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

4.  Electroporation for the efficient transfection of mammalian cells with DNA.

Authors:  G Chu; H Hayakawa; P Berg
Journal:  Nucleic Acids Res       Date:  1987-02-11       Impact factor: 16.971

5.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

6.  CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF.

Authors:  C A Smith; H J Gruss; T Davis; D Anderson; T Farrah; E Baker; G R Sutherland; C I Brannan; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

7.  The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen.

Authors:  U Latza; H Dürkop; S Schnittger; J Ringeling; F Eitelbach; M Hummel; C Fonatsch; H Stein
Journal:  Eur J Immunol       Date:  1994-03       Impact factor: 5.532

8.  A glycoprotein antigen detected with new monoclonal antibodies on the surface of human lymphocytes infected with human T-cell leukemia virus type-I (HTLV-I).

Authors:  Y Tanaka; T Inoi; H Tozawa; N Yamamoto; Y Hinuma
Journal:  Int J Cancer       Date:  1985-11-15       Impact factor: 7.396

9.  Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax.

Authors:  S Miura; K Ohtani; N Numata; M Niki; K Ohbo; Y Ina; T Gojobori; Y Tanaka; H Tozawa; M Nakamura
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

10.  Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure.

Authors:  B Seed; A Aruffo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

View more
  71 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Expansion of activated human naïve T-cells precedes effector function.

Authors:  J M Brenchley; D C Douek; D R Ambrozak; M Chatterji; M R Betts; L S Davis; R A Koup
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

3.  Gene expression profiling in MOLT-4 cells during gamma-radiation-induced apoptosis.

Authors:  Theres Lindgren; Torgny Stigbrand; Katrine Riklund; Lennart Johansson; David Eriksson
Journal:  Tumour Biol       Date:  2012-02-10

4.  GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms.

Authors:  Palash Bhattacharya; Anupama Gopisetty; Balaji B Ganesh; Jian Rong Sheng; Bellur S Prabhakar
Journal:  J Leukoc Biol       Date:  2010-11-02       Impact factor: 4.962

Review 5.  Signaling through OX40 enhances antitumor immunity.

Authors:  Shawn M Jensen; Levi D Maston; Michael J Gough; Carl E Ruby; William L Redmond; Marka Crittenden; Yuhuan Li; Sachin Puri; Christian H Poehlein; Nick Morris; Magdalena Kovacsovics-Bankowski; Tarsem Moudgil; Chris Twitty; Edwin B Walker; Hong-Ming Hu; Walter J Urba; Andrew D Weinberg; Brendan Curti; Bernard A Fox
Journal:  Semin Oncol       Date:  2010-10       Impact factor: 4.929

Review 6.  Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines.

Authors:  Lena Serghides; Mariana Vidric; Tania H Watts
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

7.  OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection.

Authors:  Y Takahashi; Y Tanaka; A Yamashita; Y Koyanagi; M Nakamura; N Yamamoto
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 8.  Next generation immune-checkpoints for cancer therapy.

Authors:  Chiara Donini; Lorenzo D'Ambrosio; Giovanni Grignani; Massimo Aglietta; Dario Sangiolo
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 9.  Science gone translational: the OX40 agonist story.

Authors:  Andrew D Weinberg; Nicholas P Morris; Magdalena Kovacsovics-Bankowski; Walter J Urba; Brendan D Curti
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

10.  Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis.

Authors:  Peyman Rajabi; Mahsa Alaee; Kazem Mousavizadeh; Ali Samadikuchaksaraei
Journal:  Inflamm Res       Date:  2012-07-31       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.